Hepatitis C virus RNA in serum as a risk factor for isoniazid hepatotoxicity.
Fernández-Villar
A
A
Sopeña
B
B
García
J
J
Gimena
B
B
Ulloa
F
F
Botana
M
M
Martínez-Vázquez
C
C
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000821:virology*; D005260:Female; D018937:Hepatitis C Antibodies / Q000097:blood; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009164:Mycobacterium Infections / Q000150:complications / Q000188:drug therapy*; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood*; D015819:Substance Abuse, Intravenous / Q000382:microbiology / Q000821:virology
D000995:Antitubercular Agents; D018937:Hepatitis C Antibodies; D012367:RNA, Viral; D007538:Isoniazid